Montefiore Health System

Montefiore and Einstein College Introduce Trials for Remdesivir-Baricitinib Combo as a Treatment Option for COVID-19

Medicine & Technology May 27, 2020

Montefiore Health System and Albert Einstein College of Medicine have begun with ACTT 2, a clinical trial using the drug combination remdesivir and baricitinib to treat patients with COVID-19. Researchers are hoping the new drug combo would reduce COVID-19-related inflammation and provide better recovery outcomes for coronavirus patients.

Boeing's Starliner to Launch Its First Crewed Mission to ISS Today

SPACE

We Strange Star's Eclipsing Mass Could Help Search For Alien Civilization as

SPACE

NASA’s JWST Detects Clouds of Melted Rock Covering the Night Side of Hot Exoplanet WASP-43b

SPACE

Montefiore Health System

Montefiore and Einstein College Introduce Trials for Remdesivir-Baricitinib Combo as a Treatment Option for COVID-19

Most Popular

Meet Goldene: The Free-Standing Sheet of Gold Only One Atom Thick

Sunscreen Myths Debunked; Expert Warns Against 'Dangerous' Sun Protection Ideas That Only Puts One at Added Risk

ESA Solar Orbiter Snaps Footage of Fluffy Plasma Structures of the Sun in Great Detail [WATCH]

Transparent Animals? These Weird Creatures Allow You To See Right Through Them

Nocebo Effect Explained: Here's How Placebo Effect's Negative Counterpart Works

Recommended Stories

Boeing's Starliner to Launch Its First Crewed Mission to ISS Today

We Strange Star's Eclipsing Mass Could Help Search For Alien Civilization as

NASA’s JWST Detects Clouds of Melted Rock Covering the Night Side of Hot Exoplanet WASP-43b

China Launches Chang’e 6 Mission To Obtain Soil and Rock Samples From the Far Side of the Moon